Chronic pain is common, and the available treatments do not provide adequate relief for most patients. Neuromodulatory interventions that modify brain processes underlying the experience of pain have the potential... read more →
About half of people with diabetes develop peripheral neuropathy. While there are some treatments to reduce pain, there’s nothing that restores sensation. Gabriel Corfas, PhD, of the F.M. Kirby Neurobiology... read more →
Chemotherapy-induced peripheral neuropathy (CIPN) is a common treatment-related adverse effect and affects long-term quality of life.1 It has the potential to result in chemotherapy dose reductions and/or early discontinuation.The purpose... read more →
A common complication of chemotherapy is neurotoxicity that often manifests itself as peripheral neuropathy. Many cancer drugs can cause chemotherapy-induced peripheral neuropathy (CIPN), and the incidence can be up to... read more →